Skip to content

To compare the antihyperglycemic effect of Tinospora crispa(L.)Hook.f.&Thomson against Tinospora cordifolia (Willd.)Miers in Type 2 Diabetes Mellitus

A comparative clinical trial on antihyperglycemic effect of Tinospora crispa(L.)Hook.f.&Thomson against Tinospora cordifolia (Willd.)Miers in Type 2 Diabetes Mellitus

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032568
Enrollment
27
Registered
2021-04-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Tinospora crispa (L.)Hook.f.&Thomson tablets : Tinospora crispa (L.)Hook.f.&Thomson tablets at a dose of 2 tablets twice daily half an hour before food in study group for 45 days Contr

Sponsors

VPSV Ayurveda College Kottakkal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. FBS 126-200mg/dl 2. PPBS 200-300mg/dl 3. Patients not on allopathic medication for Type 2 DM 4. Diagnosed cases within a period of 6 months 5. Patients willing to give written consent

Exclusion criteria

Exclusion criteria: 1. Presence of Chronic diseases or systemic illness like hypertension, dyslipidemia 2. Patients with diabetic complications 3. Patients undergoing allopathic medication for any other illness 4. Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Assessment of FBS and PPBS Timepoint: Assessment of FBS and PPBS on 0th 15th 30th 45th day

Secondary

MeasureTime frame
Assessment of subjective parameters like polyuria, polyphagia, polydipsia and burning sensation in foot and palmTimepoint: Assessment of subjective parameters before and after the study

Countries

India

Contacts

Public ContactDr N Manojkumar

VPSV Ayurveda College Kottakkal

manojkumarndr@gmail.com9447423771

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026